The tequila and offal behind South Canterbury's failed biotech gamble
Hot Topic
RICH LIST
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
The recipient of nearly $20 million in funding from Allan Hubbard and South Canterbury Finance has had doubts cast over the efficacy and ownership of his claimed cure for hepatitis.
Without a Word of a Lie has learned Biocorp Group principal Stephen John McRae was caught up in Powdergate,
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
Matt Nippert
Thu, 30 Jun 2011
Thu, 30 Jun 2011
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
The tequila and offal behind South Canterbury's failed biotech gamble
15598